Streetbeat News

Revenues

CATX

Perspective Therapeutics (AMEX:CATX) reported Q2 2024 GAAP EPS of $(0.18), beating the $(0.21) estimate. Sales were $526K, surpassing the $158.667K estimate but down 71.34% from $1.835M last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:17 pm

RAIL

FreightCar America (NASDAQ:RAIL) reported Q2 2024 earnings per share of $0.05, meeting analyst expectations. The company achieved sales of $147.416 million, surpassing the $127.100 million estimate by 15.98% and marking a 66.39% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:16 pm

DSP

Viant Technology (NASDAQ:DSP) reported Q2 2024 adjusted EPS of $0.08, significantly beating the analyst estimate of $0.01. The company also reported sales of $65.866 million, surpassing the $65.088 million estimate and marking a 15.10% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:14 pm

PACS

PACS Group has provided its revenue guidance for FY24, expecting it to be between $3.85 billion and $3.95 billion, surpassing the estimated $3.76 billion. The company also projects adjusted EBITDA to be in the range of $370 million to $380 million. PACS's portfolio includes 248 healthcare operations and 87 real estate assets, with plans to continue acquiring both performing and underperforming operations.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:12 pm

PACS

PACS Group (NYSE:PACS) reported a Q2 2024 GAAP EPS of $(0.07), missing the analyst estimate of $0.35 by 120%. However, the company reported sales of $981.85M, beating the $916.50M estimate by 7.13% and showing a 29.08% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:11 pm

RUM

Rumble anticipates sequential revenue growth throughout 2024 and aims to approach adjusted EBITDA breakeven by 2025.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:07 pm

DDI

DoubleDown Interactive (NASDAQ:DDI) reported Q2 earnings per share of $0.67, surpassing the analyst estimate of $0.49 by 36.73%. The company also reported sales of $88.24 million, beating the estimate of $83.79 million by 5.31%. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:06 pm

SKYX

SKYX Platforms (NASDAQ:SKYX) reported Q2 sales of $21.4 million, surpassing the analyst consensus estimate of $21.067 million by 1.58%. This marks a 42.67% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:06 pm

SMTK

SmartKem (NASDAQ: SMTK) reported Q2 earnings per share (EPS) of $(0.98), an improvement from $(1.82) YoY. Sales increased to $40.00K from $8.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:05 pm

GOSS

Gossamer Bio (NASDAQ:GOSS) reported Q2 2024 GAAP EPS of $0.22, beating the analyst estimate of $0.16 by 37.5%. However, the company's sales of $95.842 million missed the estimate of $114.286 million by 16.14%.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:04 pm